IP Library Granted Patent US 7,718,787
Granted Patent B2
US 7,718,787 · App. 10/530,837 · Granted May 18, 2010

Gene families associated with cancers

Assignee: LG Life Sciences Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,718,787
App. No.
10/530,837
Granted
May 18, 2010
Kind
B2
Abstract

The invention relates generally to the changes in gene expression in human tissues from cancer patients. The invention relates specifically to human gene families which are differentially expressed in cancer tissues of breast, colon, esophagus, kidney, liver, lung, lymph node, ovary, pancreas, prostate, rectum, and/or stomach compared to corresponding normal tissues.

Claims (22)

1. An isolated nucleic acid molecule consisting of:

(a) nucleotides 390-4880 of SEQ ID NO: 1;

(b) nucleotides 39-4883 of SEQ ID NO: 1;

(c) nucleotides 12-4904 of SEQ ID NO: 3;

(d) nucleotides 12-4907 of SEQ ID NO: 3;

(e) the full complement of nucleotides 390-4880 of SEQ ID NO: 1;

(f) the full complement of nucleotides 390-4883 of SEQ ID NO: 1;

(g) the full complement of nucleotides 12-4904 of SEQ ID NO: 3; or

(h) the full complement of nucleotides 12-4907 of SEQ ID NO: 3.

2. An isolated nucleic acid molecule comprising one or more heterologous expression control elements operably linked to the nucleic acid molecule of claim 1 .

3. A vector comprising the isolated nucleic acid molecule of claim 2 .

4. An isolated host cell transformed with the isolated nucleic acid molecule of claim 1 .

5. An isolated host cell comprising the vector of claim 3 .

6. The isolated host cell of claim 5 , wherein said isolated host cell is selected from the group consisting of a prokaryotic host cell and an eukaryotic host cell.

7. A method for producing a polypeptide comprising:

(i) transforming a host cell with an isolated nucleic acid molecule comprising one or more heterologous expression control elements operably linked to a nucleic acid molecule comprising:

(a) nucleotides 390-4880 of SEQ ID NO: 1,

(b) nucleotides 390-4883 of SEQ ID NO: 1,

(c) nucleotides 12-4904 of SEQ ID NO: 3, or

(d) nucleotides 12-4907 of SEQ ID NO: 3; and

(ii) culturing the transformed host cell of step (i) under suitable conditions to produce said polypeptide.

8. The method of claim 7 , wherein said host cell is selected from the group consisting of a prokaryotic host cell and an eukaryotic host cell.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2005
From: LEE, SOOJIN; KOH, SANG SEOK; LEE, BOGMAN; CHUNG, HYUN-HO; CHOO, SEUNG-HO; YANG, DOO SEOK
To: LG LIFE SCIENCES LIMITED
Reel/Frame 017085/0362 →
Continuity (1)
Related Publication 20060168670A1 · Jul 27, 2006